Unknown

Dataset Information

0

Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.


ABSTRACT:

Objective

To describe the clinico-radiologic outcome of MS patients with natalizumab-related progressive multifocal leukoencephalopathy (Nz-PML) surviving and receiving disease-modifying therapy (DMT).

Methods

We describe clinical and radiologic evolution of Nz-PML survivors in an observational retrospective multicenter cohort to clarify the effect of different subsequent MS DMT strategies. Twenty-three patients from 11 centers were analyzed. Outcomes were (1) clinical efficacy of post-PML MS DMT, (2) radiologic efficacy of post-PML MS DMT, (3) radiologic evolution of PML lesion, and (4) disability progression.

Results

There was no clinical worsening of PML symptoms with a stability of Expanded Disability Status Scale at the last follow-up. No relapse was reported with fingolimod and dimethyl fumarate. No radiologic worsening of Nz-PML lesion was observed at the end of the follow-up.

Conclusion

In this large cohort of patients with Nz-PML, MS therapies given after Nz discontinuation were not associated with PML worsening. A larger cohort with longer follow-up will be necessary to confirm this therapeutic strategy.

SUBMITTER: Maillart E 

PROVIDER: S-EPMC5462603 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Objective</h4>To describe the clinico-radiologic outcome of MS patients with natalizumab-related progressive multifocal leukoencephalopathy (Nz-PML) surviving and receiving disease-modifying therapy (DMT).<h4>Methods</h4>We describe clinical and radiologic evolution of Nz-PML survivors in an observational retrospective multicenter cohort to clarify the effect of different subsequent MS DMT strategies. Twenty-three patients from 11 centers were analyzed. Outcomes were (1) clinical efficacy of  ...[more]

Similar Datasets

| S-EPMC4241803 | biostudies-other
| S-EPMC3236516 | biostudies-literature
| S-EPMC4630686 | biostudies-literature
| S-EPMC7010325 | biostudies-literature
| S-EPMC4776091 | biostudies-literature
| S-EPMC4914441 | biostudies-literature
| S-EPMC3174071 | biostudies-literature
| S-EPMC2677530 | biostudies-literature
| S-EPMC4011468 | biostudies-literature
| S-EPMC6624093 | biostudies-literature